Beijing Challen (Challenbio) Biotechnology Co., Ltd. published new research in Molecular Cancer indicating that SerpinB7 promotes non-small cell lung cancer progression by driving glycolytic reprogramming through the SerpinB7–ANXA2–c-Myc axis.
Published
Signal category
Research & Knowledge
Quote
“New Research Published in Molecular Cancer (IF 42.2)”
— Beijing Challen (Challenbio) Biotechnology Co., Ltd. team
Company
Beijing Challen (Challenbio) Biotechnology Co., Ltd.
ChallenBio provides flow cytometers, reagents and solutions for clinical and scientific research.
- Industry
- Medical Equipment Manufacturing
- Location
- Beijing, CN
- Company size
- 7 employees
Beijing Challen Biotechnology Co., Ltd. (ChallenBio) is a leading Chinese flow cytometer manufacturer with other 17 years of experience in the industry. Challenbio provides instruments (1,2,3,4-laser and full spectrum flow cytometers), reagents and solutions for clinical and scientific research. Beijing Challen Biotechnology Co., Ltd., is a high-tech company, specializing in R&D, production and sales of biomedical technology products, located in Zhongguancun Science and Technology Park Biological Pharmaceutical Industry Base, Daxing District, Beijing. Challen Biotechnology is committed to providing users with excellent one-stop services of flow cytometry (FC), instruments and reagents. At present, Challenbio products mainly cover LongCyte™ (clinical, with CE IVDR) and FongCyte™ (reserach) flow cytometer series, as well as auxiliary diagnostic reagents and automatic sample preparation instruments. There are 700+ users worldwide. Challen Biotechnology also provides solutions for clinical diagnosis, biotherapy, basic biomedical research, drug R&D, environmental materials, food toxicity monitoring, etc.